Last reviewed · How we verify
Myramistin
Myramistin is a Small molecule drug developed by Megainpharm GmbH. It is currently in discontinued development.
At a glance
| Generic name | Myramistin |
|---|---|
| Sponsor | Megainpharm GmbH |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- A Prospective, Parallel, Single-blind Clinical Study Using Stratified Randomization of the Effectiveness, Tolerability and Safety of the Medicinal Product "Foscelantan, Medicinal Plate 4.0x5.0 cm in P (Phase 2)
- Opened, Multicenter, Randomized, in Parallel Groups Comparative Study to Assess Efficacy and Safety of Dioxidin®, Solution for Topical and External Application 0.025% (Valenta Farm, Russia) and Mirami (Phase 3)
- Treatment of Peri-implantitis by Air-polishing Abrasives and Antiseptics Solutions (NA)
- A Multi-center, Randomized, Placebo-controlled, Double-blind, Dose-finding Clinical Trial Investigating the Short-term Relief of Symptoms of Acute Pharyngitis Such as Throat Soreness Pain and Difficul (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Myramistin CI brief — competitive landscape report
- Myramistin updates RSS · CI watch RSS
- Megainpharm GmbH portfolio CI
Frequently asked questions about Myramistin
What is Myramistin?
Myramistin is a Small molecule drug developed by Megainpharm GmbH.
Who makes Myramistin?
Myramistin is developed by Megainpharm GmbH (see full Megainpharm GmbH pipeline at /company/megainpharm-gmbh).
What development phase is Myramistin in?
Myramistin is in discontinued.
Related
- Manufacturer: Megainpharm GmbH — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing